Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
REGN7544 for Low Blood Pressure from Sepsis
Recruiting0 awardsPhase 2
Boston, Massachusetts
"This trial is testing a new drug called REGN7544 on adult patients hospitalized with a serious infection called sepsis. The drug aims to improve blood pressure and reduce the need for vasopress
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service